Terminated OBSERVATIONAL NCT01114464

Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer (Resova)

Sponsor: Nantes University Hospital

Updated 11 times since 2017 Last updated: Aug 5, 2016 Started: Jan 31, 2010 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

end of normal study

Other terminated trials from Nantes University Hospital

See all terminations from Nantes University Hospital

This observational or N/A phase trial investigates Ovarian Reserve and is currently terminated or withdrawn. Nantes University Hospital leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Terminated
Sep 2024 — Sep 2025 [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Jan 2021 — Dec 2021 [monthly]

Terminated

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Terminated
Jun 2018 — Nov 2020 [monthly]

Terminated
May 2018 — Jun 2018 [monthly]

Terminated
Apr 2018 — May 2018 [monthly]

Terminated

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Terminated NA
Jan 2017 — Aug 2017 [monthly]

Terminated NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nantes University Hospital

Data source: Nantes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bordeaux, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Lille, France , Lyon, France , Montpellier, France , Paris, France , Reims, France , Rennes, France and 1 more location